Nikolaus D. Schultz - Epidemiology

Author Information

Nikolaus D. Schultz is affiliated with the Marie-Josée and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA. He is also associated with the Human Oncology and Pathogenesis Program and the Department of Epidemiology and Biostatistics at the same institution. His research focuses on molecular oncology, particularly the genomic characterization of various cancers.

Research Contributions

Nikolaus D. Schultz has made significant contributions to the field of molecular oncology and cancer genomics. In 2022 alone, he has authored multiple papers on diverse topics such as distinct genomic landscapes in endometrial cancer, metastatic patterns from clinical sequencing, and the role of the TP53 pathway in predicting response to neoadjuvant therapy in esophageal adenocarcinoma. His work often involves the use of advanced genomic and transcriptomic profiling techniques to better understand cancer behavior and treatment outcomes.

Aliases

Nikolaus D Schultz, Nikolaus D. Schultz, N Schultz, N. Schultz, Nikolaus Schultz

Publication and Citation Metrics

Metric	Value
Citation Count	136,639
h-index	112
Paper Count	517

Publications:

Distinct Genomic Landscapes in Early-Onset and Late-Onset Endometrial Cancer

DOI: 10.1200/PO.21.00401

Year: 2022

Genomic characterization of metastatic patterns from prospective clinical sequencing of 25,000 patients

DOI: 10.1016/j.cell.2022.01.003

Year: 2022

Phase II Trial of Imatinib Plus Binimetinib in Patients With Treatment-Naive Advanced Gastrointestinal Stromal Tumor

DOI: 10.1200/JCO.21.02029

Year: 2022

Genome Nexus: A Comprehensive Resource for the Annotation and Interpretation of Genomic Variants in Cancer

DOI: 10.1200/CCI.21.00144

Year: 2022

Optimal strategy and benefit of pulsed therapy depend on tumor heterogeneity and aggressiveness at time of treatment initiation.

DOI: 10.1158/1535-7163.MCT-21-0574

Year: 2022

Transcriptomic profiling to identify subsets of immune hot locally advanced rectal adenocarcinomas with favorable outcomes after neoadjuvant treatment.

DOI: 10.1200/jco.2022.40.4_suppl.155

Year: 2022

MITI minimum information guidelines for highly multiplexed tissue images.

DOI: 10.1038/s41592-022-01415-4

Year: 2022

The Role of the TP53 Pathway in Predicting Response to Neoadjuvant Therapy in Esophageal Adenocarcinoma.

DOI: 10.1158/1078-0432.CCR-21-4016

Year: 2022

Computational methods and translational applications for targeted next-generation sequencing platforms.

DOI: 10.1002/gcc.23023

Year: 2022

Association of genomic profiles and survival in early onset and screening‐age colorectal cancer patients with liver metastases resected over 15 years

DOI: 10.1002/jso.26797

Year: 2022

What is the Equator Network?

How does qPCR contribute to public health surveillance?

How Has CSSE Contributed to Epidemiology?

What are the Limitations of Culture and Sensitivity Testing?

How Can We Improve Quality of Care?

Why is Thrombolytic Therapy Important?

How Can We Prevent Emerging Diseases?

What is Serotonin?

What are the Challenges in Studying Non-Tunneled Catheters?

What are the Common Techniques Used for Pathogen Detection?

Partnered Content Networks

Relevant Topics